One Health Group (OHGR) Fair Value & Analysis
Healthcare · GB · Market cap 33.3M GBX
Fair value as of: Jul 12, 2026
From 23 valuation models · updated 29 days ago
Fair value updated Jul 12, 2026, revised from £2.37 to £3.07 (+29.5%) since Jun 24, 2026. Share price +18.2% over the past month.
A solid business, screening 24% undervalued on our models.
What matters now
- Solid quality (55/100) at a price below fair value, the discount is the argument here, not the business quality.
- A fairly wide model range (£1.84 to £3.96) leaves room in how you read the outcome.
Price vs Fair Value (17 months)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 12, 2026.
How to read this chart
17‑month range £1.42 – £2.48 · fair‑value band £1.84 – £3.96 · the £2.48 price screens below the £3.07 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 12, 2026.
Analysis
One Health Group (OHGR) currently trades at £2.48, while our model-based Fair Value estimate is £3.07, implying the stock looks roughly 24.0% undervalued today. The Quality Score stands at 55/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
The stock trades on a trailing P/E of 25.2. Fundamentals as of Jul 12, 2026
Our scenario range runs from £1.84 (bear case) to £3.96 (bull case); at £2.48, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. For context, the median of 10 Healthcare peers we cover trades at 11% fair-value upside, at 24%, OHGR screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 23 models by family
Widest divergence: Growth Earnings (£3.29) versus Asset-Based (£0.6400). Highest evidence: Growth DCF (80).
Notify me when OHGR reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
Figures from reported company fundamentals · as of Jul 12, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 58 · Market factors (momentum, volatility) 69
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
One Health Group Plc provides diagnosis and treatment for orthopedics, spine, general surgery, and gynecology patients. It provides treatments for back & spine, elbow, foot & ankle, gynaecology, hernias, hips, knees, lower GI / colorectal, shoulder, upper GI / biliary, urology, and wrist and hand, as well as surgeries, medical, and medico-legal services.
Full company description
One Health Group Plc provides diagnosis and treatment for orthopedics, spine, general surgery, and gynecology patients. It provides treatments for back & spine, elbow, foot & ankle, gynaecology, hernias, hips, knees, lower GI / colorectal, shoulder, upper GI / biliary, urology, and wrist and hand, as well as surgeries, medical, and medico-legal services. The company was incorporated in 2001 and is based in Sheffield, United Kingdom.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2023 – FY2026 · reported fiscal years
One Health Group reported revenue of £31.6M in FY2026 versus £20.5M in FY2023, a compound +15.5%/yr. Reported net income was £2.1M in FY2026, compounding +225.9%/yr from FY2023.
Watch OHGR: get an alert when its fair value changes →
Peer Group
Medical Care Facilities · 261 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Care Facilities median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Insider activity: 35/100
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jul 12, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc HCA | $378.85 | $554.93 | +46% |
| Fresenius SE FRE | €41.73 | €32.15 | -23% |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 235.00 SAR | 112.37 SAR | -52% |
| IHH Healthcare Berhad, an investment holding company, Q0F | 2.58 SGD | 1.44 SGD | -44% |
| Tenet Healthcare Corporation THC | $194.91 | $338.05 | +73% |
| Rede D'Or São Luiz S.A RDOR3 | R$36.01 | R$47.31 | +31% |
| DaVita Inc DVA | $231.61 | $255.97 | +11% |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,955 | ₹2,955 | -67% |
| Fresenius Medical Care AG FMS | $24.68 | $45.60 | +85% |
| Aier Eye Hospital Group 300015 | ¥8.68 | ¥7.67 | -12% |
Compare One Health Group with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is One Health Group (OHGR) overvalued or undervalued?
What is the fair value of OHGR?
What is the quality score of OHGR?
What is the net profit margin of OHGR?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track One Health Group and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.